THE SENATE

THE THIRTY-FIRST LEGISLATURE

REGULAR SESSION OF 2022

 

COMMITTEE ON COMMERCE AND CONSUMER PROTECTION

Senator Rosalyn H. Baker, Chair

Senator Stanley Chang, Vice Chair

 

NOTICE OF HEARING

 

 

DATE:

Wednesday, March 16, 2022

TIME:

10:00 AM

PLACE:

Conference Room 229 & Videoconference

 

PHOTO ID AND PROOF OF 1) FULL VACCINATION OR 2) A NEGATIVE COVID-19 TEST TAKEN WITHIN

72-HOURS REQUIRED FOR ENTRANCE TO THE STATE CAPITOL BEGINNING ON MARCH 7, 2022

BUILDING HOURS: 7AM TO 5PM, MONDAY - FRIDAY

This policy is subject to change and may be adjusted based on evolving COVID-19 guidelines.

Please check the Legislature’s website for updates www.capitol.hawaii.gov.

 

Effective March 7, 2022, the Legislature will accept written, videoconference, and in-person testimony at public hearings.

 

A live stream of all Senate Standing Committee meetings will be available on the Senate YouTube Channel.

 

 

A G E N D A

 

 

HB 2076, HD1

      (HSCR844-22)

      Status & Testimony

RELATING TO TOBACCO MANUFACTURER QUALIFIED ESCROW FUNDS.

Provides a mechanism to assign nonparticipating tobacco manufacturers' qualified escrow fund balances to the State.  Provides a mechanism for the financial institution acting as the escrow agent of the qualified escrow fund to petition the courts to authorize transfer of funds to the State when the qualified escrow fund is abandoned.  Effective 1/1/2222.  (HD1)

 

CPN, JDC/WAM

HB 2405, HD2

      (HSCR923-22)

      Status & Testimony

RELATING TO INSURANCE.

Prohibits health insurers, mutual benefit societies, and health maintenance organizations from applying categorical cosmetic or blanket exclusions to gender affirming treatments.  Prohibits those entities from excluding gender affirming treatments as cosmetic services when prescribed as medically necessary.  Requires those entities to provide applicants and insured persons with clear information about the coverage of gender transition services, including the process for appealing a claim denied on the basis of medical necessity.  Effective 7/1/2060.  (HD2)

 

CPN, JDC/WAM

HB 2113, HD2

      (HSCR956-22)

      Status & Testimony

RELATING TO MONEY TRANSMITTERS.

Minimizes regulatory burden and eliminates redundancy by permitting money transmitter applicants to submit to either a state or federal criminal history record check, rather than both.  Effective 1/1/2050.  (HD2)

 

CPN, JDC

HB 1478, HD2

      (HSCR931-22)

      Status & Testimony

RELATING TO PUBLIC SAFETY.

Requires property owners of residential real property to disclose, as part of the mandatory seller disclosures in real estate transactions, whether the installed smoke alarm is in accordance with existing building or residential codes based on information provided by the state fire council.  Requires the state fire council to create and maintain an informational guide on approved smoke alarms that are in accordance with existing building or residential codes and post the guide on specified websites.  Effective 7/1/2050.  (HD2)

 

CPN, JDC

HB 1516, HD1

      (HSCR832-22)

      Status & Testimony

RELATING TO REGULATION.

Prohibits as an unfair and deceptive practice the advertisement of a good or service in the absence of licenses or permits for the good or service, to the extent the licenses or permits are required by applicable state and county laws.  Effective 1/1/2050.  (HD1)

 

CPN, JDC

HB 1886, HD1

      (HSCR692-22)

      Status & Testimony

RELATING TO CONTROLLED SUBSTANCES.

Bans hemp products that contain cannabinoids created through isomerization, including Delta 8 tetrahydrocannabinol.  Adds Delta 8 tetrahydrocannabinol to the list of schedule I controlled substances.  Effective 1/1/2222.  (HD1)

 

CPN, JDC

 

Decision Making to follow, if time permits.

 

All testimony received by the Hawai‘i Senate is posted on the Hawai‘i Legislature's website, which is accessible to the public. Please do not include private information that you do not want disclosed to the public.

 

Please go to the Legislature's website, www.capitol.hawaii.gov, to submit written testimony at least 24 hours prior to the hearing. Create a free account on the website, or sign in to an existing account, then click on the "Testimony" icon on the home page to get started. While submitting your written testimony, you will be prompted to indicate if you would also like to testify at the hearing in-person or remotely via videoconference.

 

Please note the following:

 

·         The number of oral testifiers and/or time allotted to each testifier may be limited by the Chair when necessary to adhere to the committee hearing schedule. We may not be able to accommodate everyone who requests to testify orally.

·         Testifiers for this hearing will be limited to 2 minutes each.

 

If you wish to testify via videoconference during the hearing, please review the detailed step-by-step instructions for testimony procedures before you submit your written testimony. Here's a direct link to the instructions: https://capitol.hawaii.gov/docs/testimonyinstructions2022.pdf

 

For general help navigating the committee hearing process, please contact the Public Access Room at (808) 587-0478 or [email protected]. You can also visit their website at https://lrb.hawaii.gov/par/.

 

For special assistance: The cable TV broadcast and/or live stream of this meeting will include closed captioning. If you require other auxiliary aids or services to participate in the public hearing process (i.e., interpretive services (oral or written) or ASL interpreter), or are unable to submit testimony via the website due to a disability, please contact the committee at [email protected] at least 24 hours prior to the hearing.

 

For amended notices: Measures that have been deleted are stricken through and measures that have been added are underscored.  If a measure is both underscored and stricken through, that measure has been deleted from the agenda.

 

FOR FURTHER INFORMATION, PLEASE CALL THE COMMITTEE CLERK AT (808) 586-6070.

 

 

 

 

_____________________________________

Senator Rosalyn H. Baker

Chair